<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id>
<journal-title>Frontiers in Pharmacology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Pharmacol.</abbrev-journal-title>
<issn pub-type="epub">1663-9812</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1398389</article-id>
<article-id pub-id-type="doi">10.3389/fphar.2024.1398389</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pharmacology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>
<italic>In silico</italic> and <italic>in vitro</italic> chemometrics, cell toxicity and permeability of naringenin 8-sulphonate and derivatives</article-title>
<alt-title alt-title-type="left-running-head">Macedo et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2024.1398389">10.3389/fphar.2024.1398389</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Macedo</surname>
<given-names>Tiago</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1609882/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Paiva-Martins</surname>
<given-names>F&#xe1;tima</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Valent&#xe3;o</surname>
<given-names>Patr&#xed;cia</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/920077/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Pereira</surname>
<given-names>David M.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/109889/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>REQUIMTE/LAQV</institution>, <institution>Laborat&#xf3;rio de Farmacognosia</institution>, <institution>Departamento de Qu&#xed;mica</institution>, <institution>Faculdade de Farm&#xe1;cia</institution>, <institution>Universidade do Porto</institution>, <addr-line>Porto</addr-line>, <country>Portugal</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>REQUIMTE/LAQV</institution>, <institution>Departamento de Qu&#xed;mica e Bioqu&#xed;mica</institution>, <institution>Faculdade de Ci&#xea;ncias</institution>, <institution>Universidade do Porto</institution>, <addr-line>Porto</addr-line>, <country>Portugal</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/406398/overview">Sherif T. S. Hassan</ext-link>, Czech University of Life Sciences Prague, Czechia</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/18467/overview">Risto Olavi Juvonen</ext-link>, University of Eastern Finland, Finland</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1180509/overview">Shikha Joon</ext-link>, National Cancer Institute at Frederick (NIH), United States</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: David M. Pereira, <email>dpereira@ff.up.pt</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>24</day>
<month>07</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>15</volume>
<elocation-id>1398389</elocation-id>
<history>
<date date-type="received">
<day>09</day>
<month>03</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>04</day>
<month>07</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Macedo, Paiva-Martins, Valent&#xe3;o and Pereira.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Macedo, Paiva-Martins, Valent&#xe3;o and Pereira</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Background</title>
<p>Sulphur containing natural compounds are among the most biologically relevant metabolites <italic>in vivo</italic>. Naringenin 8-sulphonate from <italic>Parinari excelsa</italic> Sabine was evaluated in a previous work, demonstrating ability to act as a natural anti-inflammatory. Although the interference of this molecule against different inflammatory mediators was described, there is no information regarding its potential toxicity and pharmacokinetics, which are essential for its capacity to reach its therapeutic targets. In fact, despite the existence of reports on naringenin ADMET properties, the influence of sulphation patterns on them remains unknown.</p>
</sec>
<sec>
<title>Objectives</title>
<p>This work aims to assess the <italic>in vitro</italic> pharmacokinetic and toxicological behavior of naringenin 8-sulphonate, as well as to understand the importance of the presence and position of the sulphur containing group for that.</p>
</sec>
<sec>
<title>Methods</title>
<p>Naringenin 8-sulphonate physicochemical and ADMET properties were investigated using <italic>in silico</italic> tools and cell-based <italic>in vitro</italic> models. At the same time, naringenin and naringenin 4&#x2019;-<italic>O</italic>-sulphate were investigated to evaluate the impact of the sulphonate group on the results. ADMETlab 2.0 <italic>in silico</italic> tool was used to predict the compounds&#x2019; physicochemical descriptors. Pharmacokinetic properties were determined experimentally <italic>in vitro</italic>. While MRC-5 lung fibroblasts and HaCaT keratinocytes were used to evaluate the cytotoxicity of samples through MTT and LDH assays, Caco-2 human intestinal epithelial cells were used for the determination of genotoxicity, through alkaline comet assay, and as a permeability model to assess the ability of compounds to cross biological barriers.</p>
</sec>
<sec>
<title>Results</title>
<p>Experimental determinations showed that none of the compounds was cytotoxic. In terms of genotoxicity, naringenin 8-sulphonate and naringenin caused significant DNA fragmentation, whereas naringenin 4&#x2019;-<italic>O</italic>-sulphate did not. When it comes to permeability, the two sulphur-containing compounds with a sulphur containing group were clearly less capable to cross the Caco-2 cell barrier than naringenin.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>In this study, we conclude that the sulphur containing group from naringenin 8-sulphonate is disadvantageous for the molecule in terms of ADMET properties, being particularly impactful in the permeability in intestinal barrier models. Thus, this work provides important insights regarding the role of flavonoids sulphation and sulphonation upon pharmacokinetics and toxicity.</p>
</sec>
</abstract>
<kwd-group>
<kwd>
<italic>Parinari excelsa</italic>
</kwd>
<kwd>naringenin 8-sulphonate</kwd>
<kwd>permeability</kwd>
<kwd>pharmacokinetics</kwd>
<kwd>toxicity</kwd>
</kwd-group>
<contract-sponsor id="cn001">Funda&#xe7;&#xe3;o para a Ci&#xea;ncia e a Tecnologia<named-content content-type="fundref-id">10.13039/501100001871</named-content>
</contract-sponsor>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Ethnopharmacology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>Natural products have been of major importance in drug discovery, with many secondary metabolites having several biological properties reported. However, some natural compounds are capable of causing harmful effects in the human organism (<xref ref-type="bibr" rid="B30">Madariaga-Maz&#xf3;n et al., 2019</xref>). An efficient strategy to minimize the risk of those undesirable effects is to avoid the administration of chemically-complex natural extracts, which contain often inactive and potentially toxic compounds in their composition. For this purpose, the isolation of the compound of interest arises as a good strategy (<xref ref-type="bibr" rid="B36">Rasoanaivo et al., 2011</xref>). Nevertheless, it is important to ensure that the bioactive compounds will not lead to toxic effects themselves, through the study of their toxicological profile. Thus, as it happens with synthetic compounds, the potential toxicity of natural molecules must always be assessed before their application in therapeutics (<xref ref-type="bibr" rid="B30">Madariaga-Maz&#xf3;n et al., 2019</xref>).</p>
<p>In fact, concerning compounds safety and efficacy, several aspects should be considered besides biological activity, including absorption, distribution, metabolism, excretion and toxicity (ADMET) (<xref ref-type="bibr" rid="B28">Li et al., 2019</xref>; <xref ref-type="bibr" rid="B14">Gaohua et al., 2021</xref>; <xref ref-type="bibr" rid="B44">Zhong, 2017</xref>; <xref ref-type="bibr" rid="B9">Dulsat et al., 2023</xref>). This study is further warranted if we consider that 90% of the drug failures along the past decade were due to a poor pharmacokinetic profile (<xref ref-type="bibr" rid="B9">Dulsat et al., 2023</xref>). To avoid drugs failure during late stages of development, and the associated economical losses, ADMET prediction tools have become as an essential part of drug research (<xref ref-type="bibr" rid="B9">Dulsat et al., 2023</xref>).</p>
<p>The evergreen tree species <italic>P. excelsa</italic> Sabine is distributed across several African countries, its bark being widely used in folk medicine for the treatment of many health conditions, including anemia, diabetes, malaria, heart problems and stomach ache (<xref ref-type="bibr" rid="B22">Kamuhabwa et al., 2000</xref>; <xref ref-type="bibr" rid="B34">Ndiaye et al., 2008</xref>; <xref ref-type="bibr" rid="B12">Feitosa et al., 2012</xref>; <xref ref-type="bibr" rid="B19">Hwang et al., 2020</xref>). As previously reported by our group (<xref ref-type="bibr" rid="B29">Macedo et al., 2023</xref>), naringenin 8-sulphonate isolated from the stem bark of <italic>P. excelsa</italic> scored positively in a set of experiments to assess its anti-inflammatory potential.</p>
<p>
<italic>P. excelsa</italic> belongs to a growing group of plants with ethnopharmacological relevance that have sulphur containing flavonoids in their phytochemical composition. Other examples are: <italic>Polygonum hydropiper</italic> L., a plant used for the treatment of many health conditions, such as anxiety, gynaecological disorders, pain and ulcers (<xref ref-type="bibr" rid="B2">Bairagi et al., 2022</xref>), where isorhamnetin 3-<italic>O</italic>-sulphate may be found (<xref ref-type="bibr" rid="B40">Teles et al., 2018</xref>); <italic>Wissadula periplocifolia</italic> (L.), used in folk medicine for the treatment of liver diseases (<xref ref-type="bibr" rid="B17">Hossain et al., 2023</xref>), with several flavonoid sulphates reported in its composition, such as acacetin 7-<italic>O</italic>-sulphate, hypoaletin 3&#x2032;-<italic>O</italic>-methyl ether 8-<italic>O</italic>-sulphate and isoscutellarein 8-<italic>O</italic>-sulphate (<xref ref-type="bibr" rid="B40">Teles et al., 2018</xref>); <italic>Bixa Orellana</italic> L., a plant used as analgesic, hemostatic and wound healing (<xref ref-type="bibr" rid="B7">Coelho Dos Santos et al., 2022</xref>), which contains apigenin 7-<italic>O</italic>-sulphate and hypoaletin 8-<italic>O</italic>-sulphate (<xref ref-type="bibr" rid="B40">Teles et al., 2018</xref>).</p>
<p>Despite the promising anti-inflammatory activity revealed by naringenin 8-sulphonate from <italic>P. excelsa</italic> (<xref ref-type="bibr" rid="B29">Macedo et al., 2023</xref>), no information could be found in literature about the toxicity and pharmacokinetic behavior of this compound. For this reason, this work is focused on the prediction of ADMET properties, evaluation of the cytotoxicity in non-cancerous cell lines, genotoxicity and permeability across a biological barrier. Furthermore, the same experimental design was followed for the evaluation of naringenin and naringenin 4&#x2032;-<italic>O</italic>-sulphate, thus contributing to understand the impact of the presence and position of the sulphur group.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>2 Materials and methods</title>
<sec id="s2-1">
<title>2.1 General procedures, materials and chemicals</title>
<p>Agarose, low gelling temperature agarose, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), methylmethanesulphonate (MMS), &#x3b2;-Nicotinamide adenine dinucleotide - reduced disodium salt hydrate (NADH), dimethyl sulphoxide (DMSO), 2-(4-amidinophenyl)-6-indolecarbamidine dihydrochloride (DAPI), isopropanol, lucifer yellow CH di-potassium salt, naringenin, sodium pyruvate, Triton X-100 and trypan blue were purchased from Sigma-Aldrich (St Louis, MO, United States). Dulbecco&#x2019;s Modified Eagle Medium (DMEM) high glucose GlutaMAX&#x2122; supplemented with pyruvate, Minimum Esssential Medium (MEM) GlutaMAX&#x2122; Supplement, FBS, penicillin-streptomycin solution (penicillin 5,000 units mL<sup>-1</sup> and streptomycin 5,000&#xa0;&#x3bc;g mL<sup>-1</sup>) and trypsin-EDTA (0.25%) - phenol red were purchased from GIBCO, Invitrogen&#x2122; (Grand Island, NY, United States). Naringenin 8-sulfonate was isolated from <italic>P. excelsa</italic> through preparative thin layer chromatography (TLC) eluted with isobutanol/water/acetic acid (6:2:1), as described in <xref ref-type="bibr" rid="B29">Macedo et al. (2023)</xref>. Naringenin 4&#x2032;-<italic>O</italic>-sulphate was synthesized following the protocol described previously by the group in <xref ref-type="bibr" rid="B29">Macedo et al. (2023)</xref>. Purity of naringenin 4&#x2032;-<italic>O</italic>-sulphate and naringenin 8-sulphonate was confirmed by HPLC, being superior to 90% in both cases.</p>
</sec>
<sec id="s2-2">
<title>2.2 Cell culture and seeding</title>
<p>MRC-5 human lung fibroblast cells (Sigma-Aldrich, St. Louis, MO, United States) were cultured in MEM, while HaCaT human keratinocyte cells (ATCC, Manassas, VA, United States) and Caco-2 human intestinal epithelial cells (American Type Culture Collection, LGC Standards S.L.U., Spain) were cultured in DMEM. Both medium were supplemented with 10% of FBS and 1% of penicillin/streptomycin. Cells were incubated in 75&#xa0;cm<sup>2</sup> cell culture flasks, which were placed in an incubator at 37&#xb0;C, with a humidified atmosphere of 5% CO<sub>2</sub>. For the experiments, cells were seeded for 24&#xa0;h in 96-well plates. MRC-5 and Caco-2 were seeded at 20,000 cells/well and HaCaT were seeded at 15,000 cells/well.</p>
</sec>
<sec id="s2-3">
<title>2.3 Cell viability assay</title>
<p>Toxicity of compounds, at 50 and 100&#xa0;&#x3bc;M, was assessed against non-cancerous cell lines through the MTT assay after 24&#xa0;h of incubation, following the protocol described in <xref ref-type="bibr" rid="B29">Macedo et al., (2023)</xref>, with slight modifications. Thus, cells were exposed to MTT for 2&#xa0;h, in the case of MRC-5, and 1&#xa0;h 30&#xa0;min, in the case of HaCaT. This assay was also performed to evaluate the response of Caco-2 cells to compounds at concentrations from 125 to 1,000&#xa0;&#x3bc;M during the permeability assay, these cells being incubated for 4&#xa0;h with the samples and exposed to MTT for 2&#xa0;h. Results were expressed as percentage of viability compared to the control and correspond to the mean of, at least, three independent experiments performed in triplicate.</p>
</sec>
<sec id="s2-4">
<title>2.4 Membrane integrity assay</title>
<p>Membrane integrity was evaluated based on the LDH release to the extracellular medium. Sodium pyruvate solution was added to 50&#xa0;&#x3bc;L of supernatant collected during the viability assay protocol. Then, NADH was added and the absorbance at 340&#xa0;nm was monitored for 3&#xa0;min to evaluate the conversion of pyruvate to lactate (<xref ref-type="bibr" rid="B38">Silva et al., 2017</xref>). Triton X-100 1% was incubated for 30&#xa0;min to be used as positive control for cell lysis. Results were expressed as fold-increase compared to negative control and reflect the mean of three independent experiments, each performed in triplicate.</p>
</sec>
<sec id="s2-5">
<title>2.5 DNA damage assay</title>
<p>Caco-2 cells were incubated for 24&#xa0;h in 12 well plates at a density of 350,000 cells/well. After this, they were incubated with each sample and negative control for 24&#xa0;h and collected using 500&#xa0;&#x3bc;L of trypsin (0.25%)-ethylenediaminetetraacetic acid (EDTA) (0.038%), which was then inactivated with 1&#xa0;mL of Hanks&#x2019; Balanced Salt Solution (HBSS). The cell suspension was centrifuged at 1,200&#xa0;rpm during 8&#xa0;min at room temperature, supernatant was discarded, and cells were resuspended in 100&#xa0;&#x3bc;L of HBSS.</p>
<p>Electrophoresis was carried out to evaluate the extent of DNA fragmentation. For this, agarose-coated slides were prepared using an 1% agarose solution. A volume of 20&#xa0;&#x3bc;L from the cell suspension was involved in 170&#xa0;&#x3bc;L of 1% low gelling temperature agarose solution and applied to the slides, which were then placed at 4&#xb0;C until solidification. Slides were submerged in a lysis solution (2.5&#xa0;M NaCl, 0.1&#xa0;M EDTA, 10&#xa0;mM Tris-HCl, pH 10) with 1% Triton-X 100, at 4&#xb0;C and sheltered from the light, for 105&#xa0;min. After this, slides were submerged in the electrophoresis buffer (300&#xa0;mM NaOH, 1&#xa0;mM EDTA, pH 13) for 40&#xa0;min. A Sub-Cell GT Horizontal Electrophoresis System 15 &#xd7; 15&#xa0;cm tray (Bio-Rad Laboratories Lda, Oeiras, Portugal) was used to run the electrophoresis at 25&#xa0;V and 240&#xa0;mA during 30&#xa0;min in the dark. In the end of the electrophoresis, slides were submerged for three times in a neutralization solution (0.4&#xa0;M Tris-HCl, pH 7.5), during 5&#xa0;min each.</p>
<p>For the fluorescence microscopy analysis, DAPI was added for 15&#xa0;min at 0.5&#xa0;&#x3bc;g mL<sup>-1</sup>, the slides being washed once with HBSS in the end. Images were acquired using a Nikon Eclipse Ts2R-FL inverted microscope with a Retiga R1 camera (01-RET-R1-RM) and CFI Plan Fluor &#xd7;10 DIC objective. DNA damage was calculated using the AutoComet algorithm (<xref ref-type="bibr" rid="B4">Barbe et al., 2023</xref>) by dividing the amount of fluorescence signal correspondent to the DNA content in the comet&#x2019;s tail by the signal correspondent to the total DNA in the comet. MMS 500&#xa0;&#x3bc;M, incubated for 30&#xa0;min, was used as positive control for DNA fragmentation and consequent DNA tail formation.</p>
</sec>
<sec id="s2-6">
<title>2.6 Permeability assay</title>
<p>Caco-2 cells were seeded for 21&#xa0;days at 112,000 cells/well in Corning<sup>&#xae;</sup> 3460 Transwell<sup>&#xae;</sup> 12&#xa0;mm Polyester Membrane Inserts (Corning Incorporated, ME, United States). At every other day, culture medium was replaced and the transepithelial electrical resistance was measured to ensure values above 400 ohms until the day of the assay, to guarantee membrane integrity. For quality control purposes, Lucifer Yellow was used at 100&#xa0;&#x3bc;g mL<sup>-1</sup> in the day of the assay. Briefly, one of the inserts was incubated with Lucifer Yellow during 1&#xa0;h and, after that, its concentration was measured in the basolateral chamber, based on fluorescence intensity (&#x3bb;exc &#x3d; 485&#xa0;nm and &#x3bb;em &#x3d; 535&#xa0;nm). Lucifer Yellow passage, from the apical to the basolateral chamber equal or lower than 3% was considered indicative of a well-defined cell barrier phenotypically translated as good membrane integrity.</p>
<p>Treatments were applied in the transwells apical chamber and the basolateral chamber was filled with HBSS with calcium (1.26&#xa0;mM) and magnesium (0.81&#xa0;mM). At specific timepoints, namely 10, 20, 30, 60, 90, 120 and 180&#xa0;min, half of the volume from the basolateral chamber was collected and replaced by the same volume of HBSS. In the last time point, at 240&#xa0;min, content of both apical and basolateral compartments was collected to calculate the final mass balance. Transwells were maintained in agitation at 50&#xa0;rpm, 37&#xb0;C and 5% CO<sub>2</sub> between the timepoints.</p>
<p>Concentration of each analyte in the different compartments was determined by HPLC-DAD using a Gilson Medical Electronics HPLC system (Villiers le Bel, France), with a Spherisorb ODS<sup>&#xae;</sup> (250 &#xd7; 4.6&#xa0;mm, 5&#xa0;&#x3bc;m particle size, 100&#xa0;&#xc5; pore size) column (PSS831915, Waters, Dublin, Ireland). Elution was performed for 7&#xa0;min, with a flow rate of 900&#xa0;&#x3bc;L min<sup>-1</sup>. A mixture of methanol: water-formic acid (1%) was used as mobile phase, in a proportion of 65:35 for naringenin and 47:53 for naringenin 4&#x2019;-<italic>O</italic>-sulphate and naringenin 8-sulphonate. Quantifications were performed at 285&#xa0;nm.</p>
<p>Results were obtained from three independent experiments and each sample was analysed in triplicate. Apparent permeability (<italic>P</italic>
<sub>
<italic>app</italic>
</sub>) coefficient (cm s<sup>-1</sup>) was calculated based on the equation <italic>P</italic>
<sub>
<italic>app</italic>
</sub> &#x3d; &#x394;Q/&#x394;t&#xd7;(1/(A&#xd7;C<sub>0</sub>)), where &#x394;Q/&#x394;t represents the amount of compound over time (mol s<sup>-1</sup>), A is the monolayer area (cm<sup>2</sup>) and C0 (mol mL<sup>-1</sup>) is the initial drug concentration of the apical side (<xref ref-type="bibr" rid="B32">Nait et al., 2009</xref>; <xref ref-type="bibr" rid="B37">Silva et al., 2020</xref>).</p>
</sec>
<sec id="s2-7">
<title>2.7 <italic>In silico</italic> models and data analysis</title>
<p>Python 3.9 was used to extract from COCONUT database (<ext-link ext-link-type="uri" xlink:href="https://coconut.naturalproducts.net/">https://coconut.naturalproducts.net/</ext-link>) the available data concerning sulphur containing flavonoids. First, all the molecules belonging to the phenylpropanoids were selected, which yielded 56,527 molecules. From here, they were further narrowed down to flavonoids, yielding 27,690 compounds. Finally, filtering focusing on molecules bearing sulphur resulted in 585 molecules being extracted, which were divided in several subclasses, including isoflavonoids, aurones, neoflavonoids, among others. From those, only the subclasse &#x201c;Flavonoids&#x201d; (flavonols, flavones, flavanones, among others) was kept, to which the synthetic molecules used in this study were added. The different physicochemical and topographical features were generated using the Python RdKit library (version 2022.09.5) (<xref ref-type="bibr" rid="B26">Landrum, 2010</xref>), using each molecule&#x2019;s smile notation as input. Data was cleaned using an in-house cleaning function that involves dropping absent/null cells and use of the SimpleImputer (strategy &#x3d; &#x201c;median&#x201d;) and StandardScaler methods from the Sci-kit learn library (<xref ref-type="bibr" rid="B35">Pedregosa et al., 2011</xref>). The resulting database is provided as <xref ref-type="sec" rid="s11">Supplementary Material S1</xref>. Dimensionality reduction was done using a t-distributed stochastic neighbor embedding (t-SNE) performed using sci-kit learn with standard parameters, n_components &#x3d; 2 and n_jobs &#x3d; &#x2212;2.</p>
<p>The ADMETlab 2.0 online prediction tool (<xref ref-type="bibr" rid="B43">Xiong et al., 2021</xref>) was used to estimate compounds ADMET properties. ImageJ 1.53t and AutoComet (<xref ref-type="bibr" rid="B4">Barbe et al., 2023</xref>) were used for immunofluorescence image processing. Violin plot graphical design was performed using Numpy (<xref ref-type="bibr" rid="B15">Harris et al., 2020</xref>), Pandas (<xref ref-type="bibr" rid="B31">McKinney and WaJ, 2010</xref>), Seaborn (<xref ref-type="bibr" rid="B42">Waskom, 2021</xref>) and Matplotlib (<xref ref-type="bibr" rid="B18">Hunter, 2007</xref>) Python libraries. The remaining graphs were designed using Graph Pad Prism 8.4.2 (San Diego, CA, United States ). Analysis was performed using data from, at least, three independent experiments. Data normality was confirmed using Shapiro-Wilk normality test and comparison between treatments was performed using ANOVA test. Positive controls were compared to negative controls through the <italic>t</italic>-test. Grubb&#x2019;s test was used for outliers&#x2019; detection.</p>
</sec>
</sec>
<sec sec-type="results|discussion" id="s3">
<title>3 Results and discussion</title>
<sec id="s3-1">
<title>3.1 Chemometrics</title>
<p>Sulphur containing natural compounds are widely recognized for their importance in physiological processes occurring in several species, including humans (<xref ref-type="bibr" rid="B13">Francioso et al., 2020</xref>). Since during our previous work naringenin 4&#x2019;-<italic>O</italic>-sulphate and naringenin 8-sulphonate exhibited uncommon properties when compared to other sulphur containing flavonoids (<xref ref-type="bibr" rid="B29">Macedo et al., 2023</xref>), in this work the chemical space of these molecules was studied to understand if they could be highlighted from the others based on their physicochemical features.</p>
<p>Thus, a t-SNE algorithm was applied to naringenin 8-sulphonate, naringenin 4&#x2019;-<italic>O</italic>-sulphate and other 185 sulphur containing flavonoids (<xref ref-type="sec" rid="s11">Supplementary Material S1</xref>), selected as described in the &#x201c;<xref ref-type="sec" rid="s2">Materials and methods</xref>&#x201d; section. Indeed, among the 185 sulphur-containing flavonoids that we were able to compile from the available literature, the two compounds under study are placed in a group of four outliers in this chemical space, as can be observed in <xref ref-type="fig" rid="F1">Figure 1</xref>. The other two outliers are hesperetin 3&#x2019;-<italic>O</italic>-sulphate and [6,7-dimethoxy-2-(4-methoxyphenyl)-4-oxo-3,4-dihydro-2H-1-benzopyran-5-yl]oxidanesulphonic acid, which are also sulphur containing flavanones, the first being particularly similar to the compounds of this study. These data reinforce the interest to study the physicochemical features and pharmacodynamic properties of naringenin sulphur containing derivatives.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>t-SNE algorithm applied to sulphur containing flavonoids from COCONUT database (presented in blue) and the molecules under study naringenin 4&#x2019;-<italic>O</italic>-sulphate and naringenin 8-sulphonate (presented in orange).</p>
</caption>
<graphic xlink:href="fphar-15-1398389-g001.tif"/>
</fig>
</sec>
<sec id="s3-2">
<title>3.2 Physicochemical descriptors and drug-likeness prediction</title>
<p>Physicochemical descriptors and ADMET properties of naringenin 8-sulphonate from <italic>P. excelsa</italic> were assessed. Additionally, naringenin and naringenin 4&#x2019;-<italic>O</italic>-sulphate were studied to compare the results and understand the importance of the presence and position of the sulphur group.</p>
<p>Currently, there are several tools available for the prediction of ADMET parameters (<xref ref-type="bibr" rid="B9">Dulsat et al., 2023</xref>). One of these tools is ADMETlab 2.0, which may be highlighted from many others due to the precision, accuracy and wide coverage of parameters (<xref ref-type="bibr" rid="B9">Dulsat et al., 2023</xref>). Several physicochemical properties are considered by this tool during the evaluation of molecules and it schematizes the interval of values that each molecule should fulfil regarding several features, such as molecular weight (MW), partition coefficient (logP) or topological polar surface area (TPSA), which are parameters that have been considered along drug discovery processes of world-famous pharmaceutical industries, originating drug-likeness rules, such as Pfizer rule and GSK rule, which are also verified by ADMETlab 2.0 (<xref ref-type="bibr" rid="B43">Xiong et al., 2021</xref>). As may be seen in <xref ref-type="fig" rid="F2">Figure 2</xref>, naringenin and naringenin 4&#x2019;-<italic>O</italic>-sulphate are in the acceptable range of values for all the parameters, while naringenin 8-sulphonate has distribution coefficient (logD) and TPSA values that are outside the optimal range for a drug.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Radar charts generated by ADMETlab 2.0 tool with the chemical space of naringenin <bold>(A)</bold>, naringenin 4&#x2019;-<italic>O</italic>-sulphate <bold>(B)</bold> and naringenin 8-sulphonate <bold>(C)</bold> on the lower and upper limits of crucial features for the drug-likeness. MW, molecular weight; nRig, number of rigid bonds; fChar, Formal Charge; nHet, number of heteroatoms; MaxRing, number of atoms in the larger ring; nRing, number of rings; nRot, number of rotable bonds; TPSA, topological polar surface area; nHD, number of hydrogen bond donors; nHA, number of hydrogen bond acceptors; logD, logarithm of distribution coefficient; logS, logarithm of aqueous solubility value; logP, logarithm of partition coefficient.</p>
</caption>
<graphic xlink:href="fphar-15-1398389-g002.tif"/>
</fig>
<p>In order to transform the drug-likeness concept in a numerical score, and consequently quantify and compare values, ADMETlab 2.0 calculates the quantitative estimate of drug-likeness (QED), whose formula is based on many drug-likeness related properties, including MW, logP and TPSA. According to the tool, attractive compounds should have a QED value superior to 0.67. Regarding the tested compounds, obtained values were 0.742, 0.715, and 0.689 for naringenin, naringenin 4&#x2019;-<italic>O</italic>-sulphate and naringenin 8-sulphonate, respectively, all of them marginally exceeding the desirable threshold.</p>
<p>Besides the previously mentioned traits, among the large amount of other parameters predicted by the ADMETlab 2.0, two of them were especially relevant in this work, namely Ames toxicity, which indicates the mutagenic potential of a molecule (<xref ref-type="bibr" rid="B16">Hebert et al., 2015</xref>), and Caco-2 permeability, which was experimentally determined herein. Regarding Ames toxicity, ADMETlab 2.0 expresses the probability of a compound being toxic and qualifies it as excellent (meaning unlikely toxicity) when it is less than 0.3, medium when it is between 0.3 and 0.7, and poor when it is above 0.7. Naringenin 8-sulphonate probability was defined as 0.079, fitting in the best category. This was also the situation of naringenin 4&#x2032;-<italic>O</italic>-sulphate, whose probability was even lower (0.011). On the other hand, naringenin mutagenicity probability was 0.342, which classifies the compound as medium in this parameter. MMS, which was used in our experimental work as mutagenic positive control, had a mutagenicity probability of 0.968. When it comes to Caco-2 permeability, the tool exhibits the values in log cm s<sup>-1</sup> units and considers that values above &#x2212;5.15 translates as adequate permeability. Thus, naringenin 8-sulphonate, with a predicted permeability value of &#x2212;5.432, and its isomer naringenin 4&#x2019;-<italic>O</italic>-sulphate, with &#x2212;5.431, may be considered as poor. In opposition, the score of &#x2212;4.803 obtained by naringenin is a good indicator for its ability to cross biological barriers.</p>
</sec>
<sec id="s3-3">
<title>3.3 Cell viability assay</title>
<p>The impact of compounds on non-cancer cell lines HaCaT and MRC-5 was assessed through the MTT assay. As skin keratinocytes and lung fibroblasts, respectively, these cell lines come from two organs that are often a path for the application of anti-inflammatory drugs. In HaCaT, the decrease of cell viability was less than 15% for all the tested conditions. While naringenin 8-sulphonate decreased cell viability to 92.99% and 91.95% at 50 and 100&#xa0;&#x3bc;M, respectively, the values obtained with naringenin were 93.20% and 91.92% and with naringenin 4&#x2019;-<italic>O</italic>-sulphate were 95.42% and 89.20%. These results indicate that the three compounds have a very similar impact on HaCaT, which seems not to depend neither on the presence, nor on the position of the sulphur containing group (<xref ref-type="fig" rid="F3">Figure 3A</xref>). Regarding the effects on MRC-5, naringenin 8-sulphonate caused, once again, a slight decrease on cell viability, reducing the values to 94.77% and 94.71% at 50 and 100&#xa0;&#x3bc;M, respectively, which are acceptable. In this case, naringenin 4&#x2019;-<italic>O</italic>-sulphate caused a more pronounced viability decrease, reaching 81.48% at 100&#xa0;&#x3bc;M, still being within the range of acceptable loss of viability (<xref ref-type="bibr" rid="B20">ISO 10993-5, 2009</xref>). Naringenin did not elicit any significant decrease on MRC-5 cell viability (<xref ref-type="fig" rid="F3">Figure 3B</xref>).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Effects of naringenin, naringenin 4&#x2019;-<italic>O</italic>-sulphate and naringenin 8-sulphonate, at concentrations of 50 and 100&#xa0;&#x3bc;M, on the viability of HaCaT <bold>(A)</bold> and MRC-5 <bold>(B)</bold> cells. Topotecan (100&#xa0;&#x3bc;M) was used as positive control. Results are expressed as mean of, at least, three independent experiments, each performed in triplicate. &#x2a;<italic>p</italic> &#x3c; 0.05, &#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.001.</p>
</caption>
<graphic xlink:href="fphar-15-1398389-g003.tif"/>
</fig>
</sec>
<sec id="s3-4">
<title>3.4 Membrane integrity</title>
<p>The assessment of each molecule upon membrane integrity revealed that none of the compounds increased the extracellular LDH levels in any of the cell models (<xref ref-type="fig" rid="F4">Figure 4</xref>). These results, which point to the absence of necrosis, together with the minimal impact of the compounds on cell viability, suggest that the compounds are not cytotoxic when used at the tested concentrations.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Effects of naringenin, naringenin 4&#x2019;-<italic>O</italic>-sulphate and naringenin 8-sulphonate, at concentrations of 50 and 100&#xa0;&#x3bc;M, on the membrane integrity of HaCaT <bold>(A)</bold> and MRC-5 <bold>(B)</bold> cells. Triton X-100 (1%) was used as positive control. Results are expressed as mean of, at least, three independent experiments, each performed in triplicate. &#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.001.</p>
</caption>
<graphic xlink:href="fphar-15-1398389-g004.tif"/>
</fig>
</sec>
<sec id="s3-5">
<title>3.5 Genotoxicity</title>
<p>Comet assay was performed to evaluate possible genotoxicity of compounds. This assay is the most widely used method to assess DNA damage in eukaryotic cells and is commonly used in human biomonitoring and clinical studies (<xref ref-type="bibr" rid="B27">Langie et al., 2015</xref>; <xref ref-type="bibr" rid="B39">Subash, 2016</xref>; <xref ref-type="bibr" rid="B11">Fatima and Yadam, 2023</xref>). It is based on the principle that, under electrophoresis, fragmented DNA migrates faster than intact DNA (<xref ref-type="bibr" rid="B8">Cordelli et al., 2021</xref>). As a result, an image evocative of a comet, where the DNA that migrates faster forms the comet tail, can be seen after analysis through fluorescence microscopy (<xref ref-type="fig" rid="F5">Figure 5</xref>). The percentage of DNA in the tail may be used as a parameter to evaluate the damage on DNA (<xref ref-type="bibr" rid="B6">Clementi et al., 2021</xref>). In this work, compounds were tested at 100&#xa0;&#x3bc;M, results were collected from three independent experiments, and a total of at least 220 comets were analysed for each of the conditions.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Representative images of fluorescence microscopy, using a &#xd7;10 objective, from the negative control <bold>(A)</bold> and positive MMS control <bold>(B)</bold> of the alkaline comet assay. Zoom in of representative comets from the negative and positive controls <bold>(C)</bold>.</p>
</caption>
<graphic xlink:href="fphar-15-1398389-g005.tif"/>
</fig>
<p>Comparison of data distribution on the violin plot allows to see that there is a notorious difference between negative control and MMS positive control, which depicts the robustness of the method in detecting DNA damage. While in the negative control most of the cells have more DNA in the head of the comet, with MMS treatment most of them have more DNA in the tail. The treatment generating the most similar data compared to the negative control was with naringenin 4&#x2019;-<italic>O</italic>-sulphate (<xref ref-type="fig" rid="F6">Figure 6</xref>). Data distribution of results from naringenin and naringenin 8-sulphonate, despite being very distant from the positive control, seems to indicate that these treatments may produce some degree of genotoxic effects. In terms of statistics, the median of negative control was 20.98% of DNA in the tail, while for the positive control it was 67.12%. Regarding treatments, medians of 33.07%, 15.89% and 31.18% were obtained for naringenin, naringenin 4&#x2019;-<italic>O</italic>-sulphate and naringenin 8-sulphonate, respectively (<xref ref-type="table" rid="T1">Table 1</xref>).</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Violin plot representation of the distribution of DNA in tail percentage of each analysed cell for controls and treatments. MMS at 500&#xa0;&#x3bc;M was used as positive control, - - - - &#x003D; median; ------ &#x003D; first and third quartiles.</p>
</caption>
<graphic xlink:href="fphar-15-1398389-g006.tif"/>
</fig>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>First quartile, median and third quartile values for the distribution of cells regarding their percentage of DNA in tail.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="center">Treatment</th>
<th align="left">First quatile</th>
<th align="left">Median</th>
<th align="left">Third quartile</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">Control</td>
<td align="left">9.62</td>
<td align="left">20.98</td>
<td align="left">41.62</td>
</tr>
<tr>
<td align="left">MMS (500&#xa0;&#x3bc;M)</td>
<td align="left">48.99</td>
<td align="left">67.12</td>
<td align="left">78.85</td>
</tr>
<tr>
<td align="left">Naringenin (100&#xa0;&#x3bc;M)</td>
<td align="left">14.24</td>
<td align="left">33.07</td>
<td align="left">63.36</td>
</tr>
<tr>
<td align="left">Naringenin 4&#x2019;-O-sulphate (100&#xa0;&#x3bc;M)</td>
<td align="left">4.33</td>
<td align="left">15.89</td>
<td align="left">33.90</td>
</tr>
<tr>
<td align="left">Naringenin 8-sulphonate (100&#xa0;&#x3bc;M)</td>
<td align="left">7.25</td>
<td align="left">31.18</td>
<td align="left">66.61</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Reports concerning the mutagenic effects of naringenin are not consensual. An alkaline comet assay performed to evaluate the mutagenic effects of naringenin in HT29 cells revealed no impact on DNA integrity using concentrations up to 100&#xa0;&#x3bc;M (<xref ref-type="bibr" rid="B3">Baranowska et al., 2021</xref>). However, it may be important to refer that, despite the described methodology of this work being very similar to ours, there is no mention to a positive control, a critical part of methodological quality control, and none of the compounds caused more than 5% of DNA in comet tail, which is significantly lower than our negative control. These numerical differences may difficult the comparison of studies. In opposition, other alkaline comet assay that evaluated the effects of naringenin in different types of cells showed that naringenin was able to cause DNA damage in different cell lines, namely, MCF-7, HT-29, PC-12, and L-929 (<xref ref-type="bibr" rid="B25">Kocyigit et al., 2016</xref>). However, an effect in MCF-7 and HT-29 cells was only observed with concentrations up to 100&#xa0;&#x3bc;M, pointing to the dependence of this biological effect on the cell lines used. A comet assay performed in human umbilical vein endothelial cells (HUVECs) also confirmed the ability of naringenin to cause DNA damage at concentrations from 50&#xa0;&#x3bc;M (<xref ref-type="bibr" rid="B5">&#xc7;eker et al., 2019</xref>). Interestingly, the same study proved that naringenin could have antigenotoxic effects at lower concentrations, 8&#xa0;&#x3bc;M causing the best effects (<xref ref-type="bibr" rid="B5">&#xc7;eker et al., 2019</xref>). This possibility of distinct effects depending on the concentration used is not considered by prediction models like ADMETlab, which take into account solely the chemical structure at face value, which may be seen as a disadvantage and reinforces the importance of experimental confirmation.</p>
<p>To the best of our knowledge, there are no reports on the effects of naringenin 8-sulphonate and naringenin 4&#x2019;-<italic>O</italic>-sulphate on DNA, ours being the first. Regarding naringenin 4&#x2019;-<italic>O</italic>-sulphate, these experimental results seem to agree with the ADMETlab 2.0 prediction, since the calculated mutagenicity probability was low. The same can be postulated for naringenin, considering that the mutagenicity probability was medium. However, naringenin 8-sulphonate prediction indicated values closer to naringenin 4&#x2019;-<italic>O</italic>-sulphate, while the experimental values showed that it was closer to naringenin.</p>
</sec>
<sec id="s3-6">
<title>3.6 Permeability assay</title>
<p>The ability of naringenin 8-sulphonate to cross biological barriers was tested using a Caco-2 permeability model. The first step for this assay was to test the possible impact of high concentrations of samples in Caco-2 cells during the time of the experiment. Thus, an MTT assay, using concentrations of naringenin, naringenin 4&#x2019;-<italic>O</italic>-sulphate and naringenin 8-sulphonate until 1,000&#xa0;&#x3bc;M, was performed. Since no significant changes on cell viability were detected at the highest concentrations (<xref ref-type="fig" rid="F7">Figure 7</xref>), 1,000&#xa0;&#x3bc;M was the concentration selected for the assay.</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>Viability of Caco-2 cells after 4&#xa0;h of exposure to naringenin <bold>(A)</bold>, naringenin 4&#x2019;-<italic>O</italic>-sulphate <bold>(B)</bold> and naringenin 8-sulphonate <bold>(C)</bold>, at concentrations ranging from 125 to 1,000&#xa0;&#x3bc;M. Results are expressed as mean of, at least, three independent experiments, each performed in triplicate.</p>
</caption>
<graphic xlink:href="fphar-15-1398389-g007.tif"/>
</fig>
<p>Quantification of compounds in the basolateral chamber (<xref ref-type="fig" rid="F8">Figure 8A</xref>) at each timepoint allowed to calculate their passage from the apical chamber along time. As can be seen in <xref ref-type="fig" rid="F8">Figure 8C</xref>, few conclusions could be taken from the first 60&#xa0;min of the assay, since the results are very similar, none of the compounds reaching 10% of passage. On the other hand, from 90&#xa0;min onwards, a progressive highlight of naringenin is observed in comparison with its sulphur-containing derivatives. In fact, 32.01% of the amount of compound placed in the apical chamber in the beginning of experiment was found in the basolateral chamber after 240&#xa0;min, while 12.73% and 10.41% were the maximum percentages obtained for naringenin 4&#x2019;-<italic>O</italic>-sulphate and naringenin 8-sulphonate, respectively. This last time point was used to calculate the <italic>P</italic>
<sub>
<italic>app</italic>
</sub> coefficient, a parameter used for the classification of drugs permeability. Thus, according to the literature, the compound permeability is considered as low when <italic>P</italic>
<sub>
<italic>app</italic>
</sub> is inferior to 1 &#xd7; 10<sup>&#x2212;6</sup>&#xa0;cm s<sup>-1</sup>, moderate when it is between 1 &#xd7; 10<sup>&#x2212;6</sup>&#xa0;cm s<sup>-1</sup> and 1 &#xd7; 10<sup>&#x2212;5</sup>&#xa0;cm s<sup>-1</sup> and high when it is superior to 1 &#xd7; 10<sup>&#x2212;5</sup>&#xa0;cm s<sup>-1</sup> (<xref ref-type="bibr" rid="B23">Karakucuk et al., 2021</xref>). In this work, naringenin 8-sulphonate exhibited a <italic>P</italic>
<sub>
<italic>app</italic>
</sub> of 2.68 &#xd7; 10<sup>&#x2212;6</sup>&#xa0;cm s<sup>-1</sup>, while the values for naringenin 4&#x2019;-<italic>O</italic>-sulphate and naringenin were 3.45 &#xd7; 10<sup>&#x2212;6</sup>&#xa0;cm s<sup>-1</sup> and 8.29 &#xd7; 10<sup>&#x2212;6</sup>&#xa0;cm s<sup>-1</sup>, respectively (<xref ref-type="fig" rid="F8">Figure 8B</xref>). Converting the results from the ADMETlab 2.0 to linear values, we obtained 3.70 &#xd7; 10<sup>&#x2212;6</sup>&#xa0;cm s<sup>-1</sup>, 3.71 &#xd7; 10<sup>&#x2212;6</sup>&#xa0;cm s<sup>-1</sup> and 1,57 &#xd7; 10<sup>&#x2212;5</sup>&#xa0;cm s<sup>-1</sup> for naringenin 8-sulphonate, naringenin 4&#x2019;-<italic>O</italic>-sulphate and naringenin, respectively (<xref ref-type="table" rid="T2">Table 2</xref>). While both experimental and predictive values placed the two first compounds as moderate in terms of permeability, naringenin permeability fits in the moderate category following our experimental results, but it is considered high when we look at the ADMETlab 2.0 prediction.</p>
<fig id="F8" position="float">
<label>FIGURE 8</label>
<caption>
<p>Schematic representation of Caco-2 permeabilty model. Drawn using elements from BioRender <bold>(A)</bold>. Cumulative percentage, as a function of time, of the initial amount of naringenin, naringenin 4&#x2019;-<italic>O</italic>-sulphate and naringenin 8-sulphonate that was detected in the basolateral compartment after crossing the Caco-2 cell monolayer <bold>(B)</bold>. Apparent permeability coefficient (<italic>P</italic>
<sub>
<italic>app</italic>
</sub>) values for naringenin, naringenin 4&#x2019;-<italic>O</italic>-sulphate and naringenin 8-sulphonate across Caco-2 cell monolayers. &#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.001 compared to naringenin <bold>(C)</bold>. Results are expressed as mean and were collected from three independent experiments, performed in duplicate.</p>
</caption>
<graphic xlink:href="fphar-15-1398389-g008.tif"/>
</fig>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>
<italic>P</italic>
<sub>
<italic>app</italic>
</sub> (cm s<sup>-1</sup>) values predicted with ADMETlab 2.0 and experimentally determined with Caco-2 permeability model.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Compound</th>
<th align="left">ADMETlab 2.0</th>
<th align="left">Experimental</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">Naringenin</td>
<td align="left">1.57 &#xd7; 10<sup>&#x2212;5</sup> &#x2197;</td>
<td align="left">8.29 &#xd7; 10<sup>&#x2212;6</sup> &#x2192;</td>
</tr>
<tr>
<td align="left">Naringenin 4&#x2032;-<italic>O</italic>-sulphate</td>
<td align="left">3.71 &#xd7; 10<sup>&#x2212;6</sup> &#x2192;</td>
<td align="left">3.45 &#xd7; 10<sup>&#x2212;6</sup> &#x2192;</td>
</tr>
<tr>
<td align="left">Naringenin 8-sulphonate</td>
<td align="left">3.70 &#xd7; 10<sup>&#x2212;6</sup> &#x2192;</td>
<td align="left">2.68 &#xd7; 10<sup>&#x2212;6</sup> &#x2192;</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>&#x2192;, moderate <italic>P</italic>
<sub>
<italic>app</italic>
</sub>; &#x2197;, high <italic>P</italic>
<sub>
<italic>app</italic>
</sub> (<xref ref-type="bibr" rid="B23">Karakucuk et al., 2021</xref>).</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Through the calculation of the final mass balance, by comparing the amount initially applied with the sum of the amount collected from the basolateral side along the experiment and the amount that remained in the apical side, it was possible to conclude that there were no losses of compounds during the assay.</p>
<p>It is described in literature that flavanones show higher permeability across Caco-2 monolayers when compared to other flavonoid classes (<xref ref-type="bibr" rid="B10">Fang et al., 2017</xref>). It is also demonstrated that this permeability may be markedly decreased when they are glycosylated, since it reduces lipophilicity (<xref ref-type="bibr" rid="B10">Fang et al., 2017</xref>; <xref ref-type="bibr" rid="B33">Najmanova et al., 2020</xref>), which is in line with several studies that have shown that the decrease of lipophilicity is correlated with lower permeability (<xref ref-type="bibr" rid="B1">Arnott and Planey, 2012</xref>; <xref ref-type="bibr" rid="B33">Najmanova et al., 2020</xref>). As in the case of flavonoid glycosides, flavonoid sulphates and sulphonates are also less lipophilic than the respective aglycones, which hinders their permeability (<xref ref-type="bibr" rid="B1">Arnott and Planey, 2012</xref>). Besides, these molecules have a higher MW, which is another factor against the capacity to be absorbed (<xref ref-type="bibr" rid="B1">Arnott and Planey, 2012</xref>). Regarding the compounds of this work, as far as we know, there are no previous reports about naringenin 4&#x2019;-<italic>O</italic>-sulphate and naringenin 8-sulphonate concerning this matter. In opposition, naringenin permeability was already investigated in Caco-2 cells, with reported <italic>P</italic>
<sub>
<italic>app</italic>
</sub> values between 1.26 &#xd7; 10<sup>&#x2212;5</sup>&#xa0;cm s<sup>-1</sup> and 5.28 &#xd7; 10<sup>&#x2212;5</sup>&#xa0;cm s<sup>-1</sup> (<xref ref-type="bibr" rid="B32">Nait et al., 2009</xref>; <xref ref-type="bibr" rid="B41">Tian et al., 2009</xref>; <xref ref-type="bibr" rid="B24">Kobayashi et al., 2012</xref>). While the predictive value from ADMETlab was comprised in this range, our experimental results indicated a lower value. Even so, it is important to note that the reported values were obtained using different compound concentrations and incubation times. The ability of naringenin to cross Caco-2 has been associated with passive diffusion and active transport mechanisms by different studies (<xref ref-type="bibr" rid="B32">Nait et al., 2009</xref>; <xref ref-type="bibr" rid="B24">Kobayashi et al., 2012</xref>), one of them suggesting that the active transport is mediated by the MRP1, which is expressed in the basolateral side of the intestinal barrier (<xref ref-type="bibr" rid="B32">Nait et al., 2009</xref>). Since there are no reports regarding the transport of drug sulphate conjugates by MRP1, neither about the inhibition of this protein by those metabolites (<xref ref-type="bibr" rid="B21">Jarvinen et al., 2021</xref>), the impact of sulphation on the naringenin active transport may be difficult to predict.</p>
</sec>
</sec>
<sec sec-type="conclusion" id="s4">
<title>4 Conclusion</title>
<p>Results from previous work indicated that naringenin 8-sulphonate is more active than naringenin and naringenin 4&#x2019;-<italic>O</italic>-sulphate in terms of anti-inflammatory activity. However, the results presented herein point to less ideal ADMET properties. In fact, naringenin 8-sulphonate was the only compound from this study that did not fulfil all the ADMETlab 2.0 <italic>in silico</italic> tool criteria for proper drug-likeness and the one with the worst QED predictive value. Experimentally, it did not reveal significant cytotoxicity, but it exhibited some genotoxicity in the alkaline comet assay, as well as naringenin, and unlike naringenin 4&#x2019;-<italic>O</italic>-sulphate. This data indicates that the presence of the sulphur containing group at the position 4&#x2019; seems to nullify the genotoxic effects of naringenin, while its presence at the position 8 did not, highlighting the importance of the group position for the toxicological properties of this polyphenol. To understand whether this behaviour can be extrapolated for other flavonoids or is specific for this molecule, it would be interesting to study the impact of 4&#x2032; substitution on the mutagenicity of other flavonoids. Regarding permeability, as expected from the predicted values, the presence of a sulphur containing group greatly reduces the permeability of the molecule. Even so, naringenin 4&#x2019;-<italic>O</italic>-sulphate and naringenin 8-sulphonate permeability may be considerate as moderate, reaching values even higher than some flavonoid aglycones, such as myricetin and morin, which have reported <italic>P</italic>
<sub>
<italic>app</italic>
</sub> values of 1.70 &#xd7; 10<sup>&#x2212;6</sup>&#xa0;cm s<sup>-1</sup> and 0.62 &#xd7; 10<sup>&#x2212;6</sup>&#xa0;cm s<sup>-1</sup>, respectively (<xref ref-type="bibr" rid="B41">Tian et al., 2009</xref>). In summary, the better pharmacological effects of naringenin 8-sulphonate in comparison with naringenin 4&#x2019;-<italic>O</italic>-sulphate and naringenin, previously reported by our research group, may be, somehow, counterbalanced by its less favourable ADMET properties.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s5">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="sec" rid="s11">Supplementary Material</xref>, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s6">
<title>Ethics statement</title>
<p>Ethical approval was not required for the studies on humans in accordance with the local legislation and institutional requirements because only commercially available established cell lines were used.</p>
</sec>
<sec id="s7">
<title>Author contributions</title>
<p>TM: Data curation, Formal Analysis, Investigation, Validation, Visualization, Writing&#x2013;original draft. FP-M: Conceptualization, Methodology, Resources, Supervision, Writing&#x2013;review and editing. PV: Conceptualization, Methodology, Resources, Supervision, Writing&#x2013;review and editing. DP: Conceptualization, Data curation, Formal Analysis, Investigation, Methodology, Resources, Supervision, Validation, Visualization, Writing&#x2013;review and editing.</p>
</sec>
<sec sec-type="funding-information" id="s8">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work received support and help from FCT/MCTES (LA/P/0008/2020 DOI 10.54499/LA/P/0008/2020, UIDP/50006/2020 DOI 10.54499/UIDP/50006/2020 and UIDB/50006/2020 DOI 10.54499/UIDB/50006/2020), through national funds. Funding from PRIMA Foundation (H2020- PRIMA 2018&#x2014;Section 2, Project MILKQUA) allowed the acquisition of the fluorescence microscope. TM thanks FCT/MCTES and ESF (European Social Fund) through POCH (Programa Operacional Capital Humano) for his PhD grant (Ref. SFRH/BD/144870/2019).</p>
</sec>
<sec sec-type="COI-statement" id="s9">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
<p>The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</p>
</sec>
<sec sec-type="disclaimer" id="s10">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s11">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fphar.2024.1398389/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fphar.2024.1398389/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Table1.XLSX" id="SM1" mimetype="application/XLSX" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arnott</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Planey</surname>
<given-names>S. L.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>The influence of lipophilicity in drug discovery and design</article-title>. <source>Expert Opin. Drug Discov.</source> <volume>7</volume>, <fpage>863</fpage>&#x2013;<lpage>875</lpage>. <pub-id pub-id-type="doi">10.1517/17460441.2012.714363</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bairagi</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Saikia</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Boro</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Hazarika</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>A review on the ethnopharmacology, phytochemistry and pharmacology of Polygonum hydropiper Linn</article-title>. <source>J. Pharm. Pharmacol.</source> <volume>74</volume> (<issue>5</issue>), <fpage>619</fpage>&#x2013;<lpage>645</lpage>. <pub-id pub-id-type="doi">10.1093/jpp/rgab175</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baranowska</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Koziara</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Suliborska</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Chrzanowski</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wormstone</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Namiesnik</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Interactions between polyphenolic antioxidants quercetin and naringenin dictate the distinctive redox-related chemical and biological behaviour of their mixtures</article-title>. <source>Sci. Rep.</source> <volume>11</volume> (<issue>1</issue>), <fpage>12282</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-021-89314-0</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barbe</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Lam</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Holub</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Faghihmonzavi</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Iyer</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>AutoComet: a fully automated algorithm to quickly and accurately analyze comet assays</article-title>. <source>Redox Biol.</source> <volume>62</volume>, <fpage>102680</fpage>. <pub-id pub-id-type="doi">10.1016/j.redox.2023.102680</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>&#xc7;eker</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Orhan</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Agar</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Determination of cytotoxic, genotoxic and oxidative effects of Naringenin</article-title>. <source>Acta Biol. Turc.</source> <volume>32</volume>, <fpage>117</fpage>&#x2013;<lpage>122</lpage>.</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clementi</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Garajova</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Markkanen</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Measurement of DNA damage using the neutral comet assay in cultured cells</article-title>. <source>Bio Protoc.</source> <volume>11</volume> (<issue>22</issue>), <fpage>e4226</fpage>. <pub-id pub-id-type="doi">10.21769/BioProtoc.4226</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coelho Dos Santos</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Silva Barboza</surname>
<given-names>A. D.</given-names>
</name>
<name>
<surname>Ribeiro</surname>
<given-names>J. S.</given-names>
</name>
<name>
<surname>Rodrigues Junior</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Campos</surname>
<given-names>A. D.</given-names>
</name>
<name>
<surname>Lund</surname>
<given-names>R. G.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Bixa orellana L. (Achiote, Annatto) as an antimicrobial agent: a scoping review of its efficiency and technological prospecting</article-title>. <source>J. Ethnopharmacol.</source> <volume>287</volume>, <fpage>114961</fpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2021.114961</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cordelli</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Bignami</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Pacchierotti</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Comet assay: a versatile but complex tool in genotoxicity testing</article-title>. <source>Toxicol. Res. (Camb)</source> <volume>10</volume> (<issue>1</issue>), <fpage>68</fpage>&#x2013;<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1093/toxres/tfaa093</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dulsat</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lopez-Nieto</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Estrada-Tejedor</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Borrell</surname>
<given-names>J. I.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Evaluation of free online ADMET tools for academic or small biotech environments</article-title>. <source>Molecules</source> <volume>28</volume> (<issue>2</issue>), <fpage>776</fpage>. <pub-id pub-id-type="doi">10.3390/molecules28020776</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Study of structure and permeability relationship of flavonoids in caco-2 cells</article-title>. <source>Nutrients</source> <volume>9</volume> (<issue>12</issue>), <fpage>1301</fpage>. <pub-id pub-id-type="doi">10.3390/nu9121301</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fatima</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yadam</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>The comet assay: a straight way to estimate geno-toxicity</article-title>. <source>21st century Pathol.</source> <volume>3</volume>, <fpage>145</fpage>.</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feitosa</surname>
<given-names>E. A.</given-names>
</name>
<name>
<surname>Xavier</surname>
<given-names>H. S.</given-names>
</name>
<name>
<surname>Randau</surname>
<given-names>K. P.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Chrysobalanaceae: traditional uses, phytochemistry and pharmacology</article-title>. <source>Rev. Bras. Farmacogn.</source> <volume>22</volume> (<issue>5</issue>), <fpage>1181</fpage>&#x2013;<lpage>1186</lpage>. <pub-id pub-id-type="doi">10.1590/s0102-695x2012005000080</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Francioso</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Baseggio Conrado</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mosca</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Fontana</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Chemistry and biochemistry of sulfur natural compounds: key intermediates of metabolism and redox biology</article-title>. <source>Oxidative Med. Cell. Longev.</source> <volume>2020</volume> (<issue>1</issue>), <fpage>8294158</fpage>. <pub-id pub-id-type="doi">10.1155/2020/8294158</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gaohua</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Miao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Dou</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Crosstalk of physiological pH and chemical pKa under the umbrella of physiologically based pharmacokinetic modeling of drug absorption, distribution, metabolism, excretion, and toxicity</article-title>. <source>Expert Opin. Drug Metab. Toxicol.</source> <volume>17</volume> (<issue>9</issue>), <fpage>1103</fpage>&#x2013;<lpage>1124</lpage>. <pub-id pub-id-type="doi">10.1080/17425255.2021.1951223</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harris</surname>
<given-names>C. R.</given-names>
</name>
<name>
<surname>Millman</surname>
<given-names>K. J.</given-names>
</name>
<name>
<surname>van der Walt</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>Gommers</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Virtanen</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Cournapeau</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Array programming with NumPy</article-title>. <source>Nature</source> <volume>585</volume> (<issue>7825</issue>), <fpage>357</fpage>&#x2013;<lpage>362</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-020-2649-2</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hebert</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bishop</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bhattacharyya</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Gleason</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Torosian</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Assessment by Ames test and comet assay of toxicity potential of polymer used to develop field-capable rapid-detection device to analyze environmental samples</article-title>. <source>Appl. Nanosci.</source> <volume>5</volume> (<issue>6</issue>), <fpage>763</fpage>&#x2013;<lpage>769</lpage>. <pub-id pub-id-type="doi">10.1007/s13204-014-0373-7</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hossain</surname>
<given-names>K. N.</given-names>
</name>
<name>
<surname>Islam</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Rahman</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Sarker</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mondal</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rahman</surname>
<given-names>M. A.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>
<italic>In vitro</italic> antioxidant and <italic>in vivo</italic> hepatoprotective properties of Wissadula periplocifolia extract</article-title>. <source>ACS Omega</source> <volume>8</volume> (<issue>49</issue>), <fpage>47001</fpage>&#x2013;<lpage>47011</lpage>. <pub-id pub-id-type="doi">10.1021/acsomega.3c06614</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hunter</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Matplotlib: a 2D graphics environment</article-title>. <source>Comput. Sci. Eng.</source> <volume>9</volume> (<issue>3</issue>), <fpage>90</fpage>&#x2013;<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1109/MCSE.2007.55</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Hwang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Juliani</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Govindasamy</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Simon</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2020</year>). &#x201c;<article-title>Traditional botanical uses of non-timber forest products (NTFP)</article-title>,&#x201d; in <source>Seven counties in Liberia</source>, <fpage>3</fpage>&#x2013;<lpage>43</lpage>.</citation>
</ref>
<ref id="B20">
<citation citation-type="book">
<collab>ISO 10993-5</collab> (<year>2009</year>). <source>Biological evaluation of medical devices. Part 5: tests for <italic>in vitro</italic> cytotoxicity</source>.</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jarvinen</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Kiander</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Sinokki</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kidron</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Sjostedt</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>The role of uptake and Efflux transporters in the disposition of glucuronide and sulfate conjugates</article-title>. <source>Front. Pharmacol.</source> <volume>12</volume>, <fpage>802539</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2021.802539</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kamuhabwa</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nshimo</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>de Witte</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Cytotoxicity of some medicinal plant extracts used in Tanzanian traditional medicine</article-title>. <source>J. Ethnopharmacol.</source> <volume>70</volume> (<issue>2</issue>), <fpage>143</fpage>&#x2013;<lpage>149</lpage>. <pub-id pub-id-type="doi">10.1016/s0378-8741(99)00161-0</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karakucuk</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tashan</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Ozturk</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Celebi</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>
<italic>In vitro</italic> caco-2 cell permeability studies of ziprasidone hydrochloride monohydrate nanocrystals</article-title>. <source>Turk J. Pharm. Sci.</source> <volume>18</volume> (<issue>2</issue>), <fpage>223</fpage>&#x2013;<lpage>227</lpage>. <pub-id pub-id-type="doi">10.4274/tjps.galenos.2020.67366</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kobayashi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nagai</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Konishi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Tanabe</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Morimoto</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ogihara</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Transport mechanisms of flavanone aglycones across Caco-2 cell monolayers and artificial PAMPA membranes</article-title>. <source>J. Pharm. Pharmacol.</source> <volume>64</volume> (<issue>1</issue>), <fpage>52</fpage>&#x2013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1111/j.2042-7158.2011.01374.x</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kocyigit</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Koyuncu</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Dikilitas</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bahadori</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Turkkan</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Cytotoxic, genotoxic and apoptotic effects of naringenin-oxime relative to naringenin on normal and cancer cell lines</article-title>. <source>Asian Pac J. Trop. Biomed.</source> <volume>6</volume> (<issue>10</issue>), <fpage>872</fpage>&#x2013;<lpage>880</lpage>. <pub-id pub-id-type="doi">10.1016/j.apjtb.2016.08.004</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="web">
<person-group person-group-type="author">
<name>
<surname>Landrum</surname>
<given-names>G.</given-names>
</name>
</person-group> <year>2010</year>. <article-title>RDKit: open-source cheminformatics 2010</article-title>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://www.rdkit.org">https://www.rdkit.org</ext-link>.</comment> (<comment>Accessed January 21, 2024</comment>).</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Langie</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Azqueta</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>A. R.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>The comet assay: past, present, and future</article-title>. <source>Front. Genet.</source> <volume>6</volume>, <fpage>266</fpage>. <pub-id pub-id-type="doi">10.3389/fgene.2015.00266</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Current trends in drug metabolism and pharmacokinetics</article-title>. <source>Acta Pharm. Sin. B</source> <volume>9</volume> (<issue>6</issue>), <fpage>1113</fpage>&#x2013;<lpage>1144</lpage>. <pub-id pub-id-type="doi">10.1016/j.apsb.2019.10.001</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Macedo</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Paiva-Martins</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Ferreres</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Gomes</surname>
<given-names>N. G. M.</given-names>
</name>
<name>
<surname>Oliveira</surname>
<given-names>A. P.</given-names>
</name>
<name>
<surname>Gil-Izquierdo</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Anti-inflammatory effects of naringenin 8-sulphonate from <italic>Parinari excelsa</italic> Sabine stem bark and its semi-synthetic derivatives</article-title>. <source>Bioorg Chem.</source> <volume>138</volume>, <fpage>106614</fpage>. <pub-id pub-id-type="doi">10.1016/j.bioorg.2023.106614</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Madariaga-Maz&#xf3;n</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hern&#xe1;ndez-Alvarado</surname>
<given-names>R. B.</given-names>
</name>
<name>
<surname>Noriega-Colima</surname>
<given-names>K. O.</given-names>
</name>
<name>
<surname>Osnaya-Hern&#xe1;ndez</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Martinez-Mayorga</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Toxicity of secondary metabolites</article-title>. <source>Phys. Sci. Rev.</source> <volume>4</volume> (<issue>12</issue>). <pub-id pub-id-type="doi">10.1515/psr-2018-0116</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>McKinney</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2010</year>). &#x201c;<article-title>Data structures for statistical computing in Python</article-title>,&#x201d; in <source>Proceedings of the 9th Python in science Conference2010</source>. Editor <person-group person-group-type="editor">
<name>
<surname>WaJ</surname>
<given-names>M.</given-names>
</name>
</person-group>, <fpage>56</fpage>&#x2013;<lpage>61</lpage>.</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nait</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Al Ahmad</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Peluso</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Muller</surname>
<given-names>C. D.</given-names>
</name>
<name>
<surname>Ubeaud</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Quercetin and naringenin transport across human intestinal Caco-2 cells</article-title>. <source>J. Pharm. Pharmacol.</source> <volume>61</volume> (<issue>11</issue>), <fpage>1473</fpage>&#x2013;<lpage>1483</lpage>. <pub-id pub-id-type="doi">10.1211/jpp/61.11.0006</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Najmanova</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Voprsalova</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Saso</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Mladenka</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>The pharmacokinetics of flavanones</article-title>. <source>Crit. Rev. Food Sci. Nutr.</source> <volume>60</volume> (<issue>18</issue>), <fpage>3155</fpage>&#x2013;<lpage>3171</lpage>. <pub-id pub-id-type="doi">10.1080/10408398.2019.1679085</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ndiaye</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Diatta</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Sy</surname>
<given-names>A. N.</given-names>
</name>
<name>
<surname>Di&#xe8;ye</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Faye</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Bass&#xe8;ne</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Antidiabetic properties of aqueous barks extract of <italic>Parinari excelsa</italic> in alloxan-induced diabetic rats</article-title>. <source>Fitoterapia</source> <volume>79</volume> (<issue>4</issue>), <fpage>267</fpage>&#x2013;<lpage>270</lpage>. <pub-id pub-id-type="doi">10.1016/j.fitote.2008.01.004</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pedregosa</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Varoquaux</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Gramfort</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Michel</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Thirion</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Grisel</surname>
<given-names>O.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Scikit-learn: machine learning in Python</article-title>. <source>J. Mach. Learn Res.</source> <volume>12</volume>, <fpage>2825</fpage>&#x2013;<lpage>2830</lpage>.</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rasoanaivo</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Wright</surname>
<given-names>C. W.</given-names>
</name>
<name>
<surname>Willcox</surname>
<given-names>M. L.</given-names>
</name>
<name>
<surname>Gilbert</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Whole plant extracts versus single compounds for the treatment of malaria: synergy and positive interactions</article-title>. <source>Malar. J.</source> <volume>10</volume> (<issue>Suppl 1</issue>), <fpage>S4</fpage>. <pub-id pub-id-type="doi">10.1186/1475-2875-10-S1-S4</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Silva</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Fernandes</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Guedes de Pinho</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Remiao</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Enantioselectivity on the absorption of methylone and pentedrone using Caco-2 cell line: development and validation of an UHPLC method for cathinones quantification</article-title>. <source>Toxicol. Appl. Pharmacol.</source> <volume>395</volume>, <fpage>114970</fpage>. <pub-id pub-id-type="doi">10.1016/j.taap.2020.114970</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Silva</surname>
<given-names>T. C.</given-names>
</name>
<name>
<surname>de Andrade</surname>
<given-names>P. B.</given-names>
</name>
<name>
<surname>Paiva-Martins</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Valentao</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Pereira</surname>
<given-names>D. M.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>
<italic>In vitro</italic> anti-inflammatory and cytotoxic effects of aqueous extracts from the edible sea anemones <italic>Anemonia sulcata</italic> and <italic>Actinia equina</italic>
</article-title>. <source>Int. J. Mol. Sci.</source> <volume>18</volume> (<issue>3</issue>), <fpage>653</fpage>. <pub-id pub-id-type="doi">10.3390/ijms18030653</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Subash</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Assessment of oxidative DNA damage by alkaline comet assay in human essential hypertension</article-title>. <source>Indian J. Clin. Biochem.</source> <volume>31</volume> (<issue>2</issue>), <fpage>185</fpage>&#x2013;<lpage>193</lpage>. <pub-id pub-id-type="doi">10.1007/s12291-015-0521-1</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Teles</surname>
<given-names>Y. C. F.</given-names>
</name>
<name>
<surname>Souza</surname>
<given-names>M. S. R.</given-names>
</name>
<name>
<surname>Souza</surname>
<given-names>M. F. V.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Sulphated flavonoids: biosynthesis, structures, and biological activities</article-title>. <source>Molecules</source> <volume>23</volume> (<issue>2</issue>), <fpage>480</fpage>. <pub-id pub-id-type="doi">10.3390/molecules23020480</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tian</surname>
<given-names>X.-J.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X.-W.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Studies of intestinal permeability of 36 flavonoids using Caco-2 cell monolayer model</article-title>. <source>Int. J. Pharm.</source> <volume>367</volume>, <fpage>58</fpage>&#x2013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijpharm.2008.09.023</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Waskom</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>seaborn: statistical data visualization</article-title>. <source>J. Open Source Softw.</source> <volume>6</volume>, <fpage>3021</fpage>. <pub-id pub-id-type="doi">10.21105/joss.03021</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xiong</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Yi</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Hsieh</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties</article-title>. <source>Nucleic Acids Res.</source> <volume>49</volume> (<issue>W1</issue>), <fpage>W5</fpage>&#x2013;<lpage>W14</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkab255</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Zhong</surname>
<given-names>H. A.</given-names>
</name>
</person-group> <year>2017</year>. &#x201c;<article-title>ADMET properties: overview and current topics</article-title>,&#x201d; in <source>Drug design: principles and Applications2017</source>, <fpage>113</fpage>&#x2013;<lpage>133</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>